Cargando…
Notes from the Field: Acquisition of Delamanid Under a Compassionate Use Program for Extensively Drug-Resistant Tuberculosis — United States, 2017
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132180/ https://www.ncbi.nlm.nih.gov/pubmed/30188880 http://dx.doi.org/10.15585/mmwr.mm6735a6 |
_version_ | 1783354273741930496 |
---|---|
author | Lardizabal, Alfred A. Khan, Anum N. Bamrah Morris, Sapna Goswami, Neela D. |
author_facet | Lardizabal, Alfred A. Khan, Anum N. Bamrah Morris, Sapna Goswami, Neela D. |
author_sort | Lardizabal, Alfred A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6132180 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-61321802018-09-24 Notes from the Field: Acquisition of Delamanid Under a Compassionate Use Program for Extensively Drug-Resistant Tuberculosis — United States, 2017 Lardizabal, Alfred A. Khan, Anum N. Bamrah Morris, Sapna Goswami, Neela D. MMWR Morb Mortal Wkly Rep Notes from the Field Centers for Disease Control and Prevention 2018-09-07 /pmc/articles/PMC6132180/ /pubmed/30188880 http://dx.doi.org/10.15585/mmwr.mm6735a6 Text en https://creativecommons.org/licenses/by/3.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated. |
spellingShingle | Notes from the Field Lardizabal, Alfred A. Khan, Anum N. Bamrah Morris, Sapna Goswami, Neela D. Notes from the Field: Acquisition of Delamanid Under a Compassionate Use Program for Extensively Drug-Resistant Tuberculosis — United States, 2017 |
title | Notes from the Field: Acquisition of Delamanid Under a Compassionate Use Program for Extensively Drug-Resistant Tuberculosis — United States, 2017 |
title_full | Notes from the Field: Acquisition of Delamanid Under a Compassionate Use Program for Extensively Drug-Resistant Tuberculosis — United States, 2017 |
title_fullStr | Notes from the Field: Acquisition of Delamanid Under a Compassionate Use Program for Extensively Drug-Resistant Tuberculosis — United States, 2017 |
title_full_unstemmed | Notes from the Field: Acquisition of Delamanid Under a Compassionate Use Program for Extensively Drug-Resistant Tuberculosis — United States, 2017 |
title_short | Notes from the Field: Acquisition of Delamanid Under a Compassionate Use Program for Extensively Drug-Resistant Tuberculosis — United States, 2017 |
title_sort | notes from the field: acquisition of delamanid under a compassionate use program for extensively drug-resistant tuberculosis — united states, 2017 |
topic | Notes from the Field |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132180/ https://www.ncbi.nlm.nih.gov/pubmed/30188880 http://dx.doi.org/10.15585/mmwr.mm6735a6 |
work_keys_str_mv | AT lardizabalalfreda notesfromthefieldacquisitionofdelamanidunderacompassionateuseprogramforextensivelydrugresistanttuberculosisunitedstates2017 AT khananumn notesfromthefieldacquisitionofdelamanidunderacompassionateuseprogramforextensivelydrugresistanttuberculosisunitedstates2017 AT bamrahmorrissapna notesfromthefieldacquisitionofdelamanidunderacompassionateuseprogramforextensivelydrugresistanttuberculosisunitedstates2017 AT goswamineelad notesfromthefieldacquisitionofdelamanidunderacompassionateuseprogramforextensivelydrugresistanttuberculosisunitedstates2017 |